{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:59:39Z","timestamp":1792144779194,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012729","name":"Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008523","name":"Center for Clinical and Translational Science, University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.mayocp.2022.02.016","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:02:52Z","timestamp":1654084972000},"page":"1074-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Newer P2Y12 Inhibitors vs Clopidogrel in Acute Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-0217","authenticated-orcid":false,"given":"Sri Harsha","family":"Patlolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harika","family":"Kandlakunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind R.","family":"Kuchkuntla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajar","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Tanveer","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-8238","authenticated-orcid":false,"given":"Saraschandra","family":"Vallabhajosyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2022.02.016_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1938","article-title":"Twenty-year trends in outcomes for older adults with acute myocardial infarction in the United States","volume":"2","author":"Krumholz","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.mayocp.2022.02.016_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-124-3-199602010-00002","article-title":"Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes","volume":"124","author":"Krumholz","year":"1996","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2022.02.016_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00392-020-01612-1","article-title":"Temporal trends in incidence and outcome of acute coronary syndrome","volume":"109","author":"Neumann","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"9973","key":"10.1016\/j.mayocp.2022.02.016_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(14)61932-2","article-title":"Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study","volume":"385","author":"Nallamothu","year":"2015","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.mayocp.2022.02.016_bib5","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.mayocp.2022.02.016_bib6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.mayocp.2022.02.016_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.mayocp.2022.02.016_bib8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2022.02.016_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.02.016_bib10","doi-asserted-by":"crossref","first-page":"16794","DOI":"10.1038\/s41598-020-73871-x","article-title":"Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis","volume":"10","author":"Fei","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.mayocp.2022.02.016_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resuscitation.2020.07.022","article-title":"Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000-2017","volume":"155","author":"Vallabhajosyula","year":"2020","journal-title":"Resuscitation"},{"issue":"3","key":"10.1016\/j.mayocp.2022.02.016_bib12","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/ehf2.13321","article-title":"Epidemiology of cardiogenic shock and cardiac arrest complicating non-ST-segment elevation myocardial infarction: 18-year US study","volume":"8","author":"Vallabhajosyula","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.mayocp.2022.02.016_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.amjcard.2020.07.044","article-title":"Long-term outcomes of acute myocardial infarction with concomitant cardiogenic shock and cardiac arrest","volume":"133","author":"Vallabhajosyula","year":"2020","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.02.016_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ccd.22248","article-title":"A\u00a0comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction","volume":"75","author":"Osmancik","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.mayocp.2022.02.016_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00228-012-1360-0","article-title":"Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR)","volume":"69","author":"Souckova","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.02.016_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ehjcvp\/pvaa009","volume":"7","author":"Gorog","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.mayocp.2022.02.016_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.resuscitation.2015.11.006","article-title":"Stent thrombosis after primary percutaneous coronary intervention in comatose survivors of out-of-hospital cardiac arrest: are the new P2Y12 inhibitors really more effective than clopidogrel?","volume":"98","author":"Gouffran","year":"2016","journal-title":"Resuscitation"},{"key":"10.1016\/j.mayocp.2022.02.016_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.resuscitation.2017.02.015","article-title":"Out-of-hospital cardiac arrest and stent thrombosis: ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia","volume":"114","author":"Jimenez-Britez","year":"2017","journal-title":"Resuscitation"},{"issue":"5","key":"10.1016\/j.mayocp.2022.02.016_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.resuscitation.2014.02.004","article-title":"High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest","volume":"85","author":"Ibrahim","year":"2014","journal-title":"Resuscitation"},{"issue":"6","key":"10.1016\/j.mayocp.2022.02.016_bib20","first-page":"1190","article-title":"Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: results of the ISAR-SHOCK registry","volume":"112","author":"Orban","year":"2014","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.mayocp.2022.02.016_bib21","doi-asserted-by":"crossref","first-page":"e1395","DOI":"10.4244\/EIJY15M12_04","article-title":"ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis","volume":"12","author":"Orban","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.mayocp.2022.02.016_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4172\/2329-6607.1000175","article-title":"Impact of the new P2Y12 receptor inhibitors on mortality in STElevation myocardial infarction patients with cardiogenic shock and \/ or after cardiopulmonary resuscitation undergoing percutaneous coronary intervention","volume":"5","author":"Kanic","year":"2016","journal-title":"Cardiovasc Pharm Open Access"},{"issue":"11","key":"10.1016\/j.mayocp.2022.02.016_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mayocp.2022.02.016_bib24","author":"Wells"},{"issue":"17","key":"10.1016\/j.mayocp.2022.02.016_bib25","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mayocp.2022.02.016_bib26","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2022.02.016_bib27","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A\u00a0GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.mayocp.2022.02.016_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.mayocp.2022.02.016_bib31","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.116.024872","article-title":"Ticagrelor versus clopidogrel in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and hypothermia: a randomized study","volume":"134","author":"Steblovnik","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2022.02.016_bib29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cjca.2014.07.745","article-title":"Superiority of ticagrelor over clopidogrel in patients after cardiac arrest undergoing therapeutic hypothermia","volume":"30","author":"Moudgil","year":"2014","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.02.016_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11239-015-1274-7","article-title":"Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction","volume":"41","author":"Bednar","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"10","key":"10.1016\/j.mayocp.2022.02.016_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcin.2016.02.013","article-title":"Optimal P2Y12 inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a network meta-analysis","volume":"9","author":"Rafique","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.mayocp.2022.02.016_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jacc.2010.07.012","article-title":"New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis","volume":"56","author":"Bellemain-Appaix","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.mayocp.2022.02.016_bib34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2019.01.053","article-title":"Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock","volume":"73","author":"Vallabhajosyula","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2022.02.016_bib35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00134-004-2425-z","article-title":"Mode of death after admission to an intensive care unit following cardiac arrest","volume":"30","author":"Laver","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mayocp.2022.02.016_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.resuscitation.2019.01.031","article-title":"Reasons for death in patients successfully resuscitated from out-of-hospital and in-hospital cardiac arrest","volume":"136","author":"Witten","year":"2019","journal-title":"Resuscitation"},{"issue":"12","key":"10.1016\/j.mayocp.2022.02.016_bib37","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1161\/CIR.0000000000000747","article-title":"Sudden cardiac arrest survivorship: a scientific statement from the American Heart Association","volume":"141","author":"Sawyer","year":"2020","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.mayocp.2022.02.016_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1816897","article-title":"Coronary angiography after cardiac arrest without ST-segment elevation","volume":"380","author":"Lemkes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2022.02.016_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcin.2021.01.024","article-title":"Effect of CYP2C19 genotype on ischemic outcomes during oral P2Y12 inhibitor therapy: a meta-analysis","volume":"14","author":"Pereira","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.mayocp.2022.02.016_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.acvd.2016.01.009","article-title":"One-year incidence and clinical impact of bleeding events in patients treated with prasugrel or clopidogrel after ST-segment elevation myocardial infarction","volume":"109","author":"Lattuca","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2022.02.016_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40119-019-00152-8","article-title":"Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature","volume":"8","author":"Subramaniam","year":"2019","journal-title":"Cardiol Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2022.02.016_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41569-018-0118-5","article-title":"Predictors of stent thrombosis and their implications for clinical practice","volume":"16","author":"Gori","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"25","key":"10.1016\/j.mayocp.2022.02.016_bib43","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.02.016_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1074248417724869","article-title":"Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes","volume":"23","author":"Esteve-Pastor","year":"2018","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.mayocp.2022.02.016_bib45","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/phar.2018","article-title":"Contemporary time trends in use of antiplatelet agents among patients with acute coronary syndrome and comorbid diabetes mellitus or chronic kidney disease","volume":"37","author":"Desai","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.mayocp.2022.02.016_bib46","article-title":"Ticagrelor use in acute myocardial infarction: insights from the National Cardiovascular Data Registry","volume":"7","author":"Basra","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.mayocp.2022.02.016_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006692","article-title":"Understanding how cardiac arrest complicates the analysis of clinical trials of cardiogenic shock","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T18:31:07Z","timestamp":1654367467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0025619622001203"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.02.016","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newer P2Y12 Inhibitors vs Clopidogrel in Acute Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}